J Med Assoc Thai 2013; 96 (6):756

Views: 1,940 | Downloads: 60 | Responses: 0

PDF XML Respond to this article Print Alert & updates Request permissions Email to a friend

131I-Rituximab Treatment in Patient with Relapsed Non-Hodgkin’s Lymphoma: The First Case Report in Thailand
Kositwattanarerk A Mail, Changmuang W , Sangsuriyan J , Thongklam K , Sritara C , Utamakul C , Chamroonrat W , Thamnirat K , Anongpornyochkul Y , Chancharunee S

Radioimmunotherapy (RIT) with 131I-rituximab is a safe and effective treatment in patients with relapsed, refractory follicular lymphoma. The authors demonstrated the first case of 131I-rituximab treatment in the patient with relapsed non-Hodgkin’s lymphoma (NHL) in Thailand. There was no immediate complication after treatment. Impressive treatment response occurred.

Keywords: 131I-rituximab, Non-Hodgkin’s lymphoma, Radioimmunotherapy

Download: PDF